South Africa has become the second African country to approve the use of an injectable form of PrEP that lasts for two months as a powerful new HIV prevention option.
Pre-exposure prophylaxis (PrEP) or HIV prevention medication has been hailed as our best line of defence against the virus.
Research reveals that six out of seven new HIV infections among 15-19-year-olds in Sub Saharan Africa are among girls.